Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI ; volume:02 ; number:02 ; year:2017 ; pages:019-023
Indian Journal of Cardiovascular Disease in Women WINCARS ; 02, Heft 02 (2017), 019-023
- Contributor
-
Ram, V. Seetha
Lalita, N.
Jyotsna, Maddury
- DOI
-
10.1055/s-0038-1656404
- URN
-
urn:nbn:de:101:1-2018121608050597376530
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2024, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ram, V. Seetha
- Lalita, N.
- Jyotsna, Maddury
Other Objects (12)
Genetic determinants of platelet response to clopidogrel
Cemsky (1990), Briese, CYP
115-155, CON-CYP
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
selbst Salvatore der PCI
Genetic determinants of platelet response to clopidogrel
Cemsky (1990), Briese, CYP
115-155, CON-CYP
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
selbst Salvatore der PCI
Genetic determinants of platelet response to clopidogrel
Cemsky (1990), Briese, CYP
115-155, CON-CYP
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6